SL Science Holding Ltd (SLBT) stock
SLBTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 18, 2026
$0.66+0.02 (+3.90%)
Close on Nov 18, 2026Market cap $370.05MP/E –Yield –
SL Science operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
No operating income figures for SL Science
SL Science has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?